MK0782

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0782, covering 2015-06-11 to 2015-06-11. Get the full timeline:

Most recent: Clinical Trial Update: MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001) [Phase 2]